Voloridge Investment Management, LLC Adverum Biotechnologies, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $534,941 - $775,230	-54,364 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $452,211 - $950,082	43,904 Added 419.73%	54,364 $560,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $164,287 - $493,826	-19,260 Reduced 64.8%	10,460 $218,000
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $237,165 - $485,030	29,720 New	29,720 $290,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $593,720 - $1.42 Million	-115,961 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $607,635 - $1.84 Million	115,961 New	115,961 $632,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.